| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Regulation, Neoplastic | 59 | 2026 | 2021 | 2.720 |
Why?
|
| MicroRNAs | 32 | 2025 | 902 | 2.680 |
Why?
|
| Transcriptome | 28 | 2024 | 1132 | 2.360 |
Why?
|
| DNA Methylation | 31 | 2026 | 1092 | 2.310 |
Why?
|
| Receptors, Androgen | 20 | 2026 | 414 | 2.310 |
Why?
|
| Hyperoxia | 9 | 2023 | 135 | 2.010 |
Why?
|
| Epigenesis, Genetic | 32 | 2026 | 772 | 1.860 |
Why?
|
| Cell Line, Tumor | 80 | 2026 | 3703 | 1.820 |
Why?
|
| Mice | 129 | 2026 | 18246 | 1.660 |
Why?
|
| Gene Expression Regulation | 26 | 2026 | 2344 | 1.620 |
Why?
|
| Epigenomics | 12 | 2025 | 183 | 1.560 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 8 | 2026 | 101 | 1.500 |
Why?
|
| Animals | 155 | 2026 | 33938 | 1.480 |
Why?
|
| Cell Proliferation | 51 | 2026 | 2477 | 1.380 |
Why?
|
| Prostatic Neoplasms | 17 | 2026 | 1387 | 1.370 |
Why?
|
| Osteosarcoma | 6 | 2024 | 268 | 1.340 |
Why?
|
| Signal Transduction | 47 | 2025 | 4675 | 1.300 |
Why?
|
| Biomarkers, Tumor | 20 | 2025 | 1607 | 1.280 |
Why?
|
| Transcription Factors | 27 | 2026 | 2442 | 1.250 |
Why?
|
| Bone Neoplasms | 7 | 2024 | 444 | 1.240 |
Why?
|
| Lung Injury | 6 | 2023 | 123 | 1.230 |
Why?
|
| RNA, Long Noncoding | 10 | 2022 | 227 | 1.210 |
Why?
|
| Insulin Resistance | 8 | 2025 | 683 | 1.180 |
Why?
|
| Estrogen Receptor alpha | 7 | 2026 | 432 | 1.130 |
Why?
|
| Tuberculosis | 7 | 2024 | 555 | 1.080 |
Why?
|
| Software | 10 | 2020 | 736 | 1.050 |
Why?
|
| Metabolome | 11 | 2024 | 325 | 1.030 |
Why?
|
| Humans | 223 | 2026 | 130842 | 1.030 |
Why?
|
| Organoids | 9 | 2026 | 306 | 1.020 |
Why?
|
| Bronchopulmonary Dysplasia | 7 | 2024 | 214 | 0.990 |
Why?
|
| Breast Neoplasms | 17 | 2026 | 2648 | 0.990 |
Why?
|
| Proteomics | 7 | 2021 | 606 | 0.970 |
Why?
|
| Gene Expression Profiling | 29 | 2025 | 1844 | 0.960 |
Why?
|
| Carcinoma, Squamous Cell | 11 | 2022 | 756 | 0.940 |
Why?
|
| Liver | 12 | 2026 | 1801 | 0.930 |
Why?
|
| Genome, Human | 14 | 2019 | 1323 | 0.890 |
Why?
|
| Protein Array Analysis | 3 | 2022 | 104 | 0.870 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2025 | 816 | 0.860 |
Why?
|
| Xenograft Model Antitumor Assays | 27 | 2026 | 996 | 0.850 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 6 | 2025 | 54 | 0.830 |
Why?
|
| Lamin Type A | 6 | 2021 | 13 | 0.810 |
Why?
|
| Metabolomics | 10 | 2024 | 501 | 0.810 |
Why?
|
| Repressor Proteins | 9 | 2024 | 772 | 0.800 |
Why?
|
| Antineoplastic Agents | 13 | 2023 | 1794 | 0.790 |
Why?
|
| Urinary Bladder Neoplasms | 8 | 2026 | 492 | 0.790 |
Why?
|
| DNA Damage | 7 | 2026 | 519 | 0.790 |
Why?
|
| Leukemia, Myeloid, Acute | 8 | 2021 | 578 | 0.770 |
Why?
|
| Male | 102 | 2026 | 64715 | 0.760 |
Why?
|
| Fatty Acids | 7 | 2026 | 378 | 0.760 |
Why?
|
| Lung Neoplasms | 10 | 2023 | 1538 | 0.760 |
Why?
|
| Carcinoma, Renal Cell | 5 | 2025 | 221 | 0.750 |
Why?
|
| Nuclear Proteins | 15 | 2020 | 1218 | 0.750 |
Why?
|
| Intestinal Mucosa | 6 | 2025 | 769 | 0.740 |
Why?
|
| Female | 101 | 2026 | 70670 | 0.730 |
Why?
|
| Lung | 12 | 2026 | 1580 | 0.720 |
Why?
|
| Enterocytes | 2 | 2024 | 68 | 0.710 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2020 | 483 | 0.700 |
Why?
|
| Skin Neoplasms | 8 | 2022 | 903 | 0.690 |
Why?
|
| Glucose | 11 | 2023 | 848 | 0.680 |
Why?
|
| DNA Repair | 9 | 2026 | 580 | 0.680 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2021 | 45 | 0.670 |
Why?
|
| Cardiomyopathies | 6 | 2025 | 517 | 0.660 |
Why?
|
| Intestinal Neoplasms | 1 | 2021 | 36 | 0.660 |
Why?
|
| Myocytes, Cardiac | 7 | 2021 | 675 | 0.660 |
Why?
|
| Ileum | 1 | 2021 | 109 | 0.650 |
Why?
|
| Mammary Glands, Animal | 4 | 2020 | 447 | 0.640 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2022 | 733 | 0.620 |
Why?
|
| Sex Characteristics | 3 | 2021 | 329 | 0.620 |
Why?
|
| Gene Regulatory Networks | 9 | 2022 | 380 | 0.610 |
Why?
|
| Apoptosis | 25 | 2021 | 1854 | 0.610 |
Why?
|
| DNA | 8 | 2026 | 1412 | 0.600 |
Why?
|
| Cell Differentiation | 13 | 2025 | 1921 | 0.600 |
Why?
|
| Carcinogenesis | 10 | 2023 | 351 | 0.590 |
Why?
|
| CpG Islands | 13 | 2024 | 339 | 0.580 |
Why?
|
| Phosphoproteins | 8 | 2020 | 430 | 0.580 |
Why?
|
| Membrane Proteins | 10 | 2021 | 1607 | 0.570 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2021 | 358 | 0.570 |
Why?
|
| Trans-Activators | 7 | 2024 | 683 | 0.570 |
Why?
|
| Mice, Knockout | 26 | 2025 | 3840 | 0.570 |
Why?
|
| Zebrafish | 4 | 2026 | 421 | 0.560 |
Why?
|
| Cigarette Smoking | 3 | 2026 | 95 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 18 | 2026 | 4709 | 0.560 |
Why?
|
| Histone-Lysine N-Methyltransferase | 5 | 2021 | 165 | 0.550 |
Why?
|
| Neoplastic Stem Cells | 8 | 2019 | 328 | 0.550 |
Why?
|
| Head and Neck Neoplasms | 4 | 2025 | 636 | 0.540 |
Why?
|
| Testis | 6 | 2021 | 399 | 0.540 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2021 | 276 | 0.540 |
Why?
|
| Kidney Neoplasms | 4 | 2025 | 419 | 0.530 |
Why?
|
| Pancreatic Neoplasms | 6 | 2021 | 744 | 0.520 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2020 | 202 | 0.520 |
Why?
|
| Disease Models, Animal | 28 | 2026 | 4669 | 0.520 |
Why?
|
| Myeloproliferative Disorders | 4 | 2021 | 93 | 0.520 |
Why?
|
| Caliciviridae Infections | 3 | 2026 | 287 | 0.520 |
Why?
|
| Transcription, Genetic | 13 | 2026 | 1382 | 0.510 |
Why?
|
| Mutation | 18 | 2026 | 6150 | 0.510 |
Why?
|
| Sequence Analysis, DNA | 11 | 2018 | 1729 | 0.510 |
Why?
|
| Cell Movement | 13 | 2021 | 872 | 0.510 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 1423 | 0.510 |
Why?
|
| Proteins | 6 | 2021 | 1006 | 0.500 |
Why?
|
| NF-E2-Related Factor 2 | 4 | 2025 | 130 | 0.500 |
Why?
|
| Energy Metabolism | 7 | 2026 | 796 | 0.500 |
Why?
|
| Norovirus | 3 | 2026 | 285 | 0.500 |
Why?
|
| Intestines | 5 | 2026 | 591 | 0.500 |
Why?
|
| Host-Pathogen Interactions | 3 | 2026 | 256 | 0.500 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 198 | 0.480 |
Why?
|
| DNA-Binding Proteins | 10 | 2025 | 1950 | 0.470 |
Why?
|
| Zebrafish Proteins | 3 | 2026 | 132 | 0.470 |
Why?
|
| Neurons | 6 | 2021 | 2008 | 0.470 |
Why?
|
| Alveolar Epithelial Cells | 3 | 2026 | 38 | 0.460 |
Why?
|
| High-Throughput Nucleotide Sequencing | 12 | 2020 | 916 | 0.460 |
Why?
|
| Nuclear Receptor Coactivator 2 | 4 | 2018 | 148 | 0.460 |
Why?
|
| Genomic Instability | 6 | 2025 | 246 | 0.450 |
Why?
|
| Histones | 10 | 2026 | 543 | 0.450 |
Why?
|
| Sarcoma, Ewing | 3 | 2023 | 117 | 0.450 |
Why?
|
| Neuroblastoma | 5 | 2022 | 557 | 0.450 |
Why?
|
| Computational Biology | 11 | 2020 | 867 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-myc | 7 | 2025 | 193 | 0.440 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 334 | 0.430 |
Why?
|
| Morphogenesis | 2 | 2026 | 191 | 0.430 |
Why?
|
| Liver Neoplasms | 8 | 2024 | 1395 | 0.420 |
Why?
|
| Cisplatin | 4 | 2025 | 273 | 0.420 |
Why?
|
| Single-Cell Analysis | 5 | 2026 | 361 | 0.420 |
Why?
|
| Genome | 4 | 2018 | 467 | 0.420 |
Why?
|
| Physical Conditioning, Animal | 3 | 2020 | 85 | 0.410 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2020 | 619 | 0.410 |
Why?
|
| Adenocarcinoma | 5 | 2026 | 988 | 0.410 |
Why?
|
| Obesity | 9 | 2025 | 2390 | 0.410 |
Why?
|
| Tumor Cells, Cultured | 13 | 2021 | 963 | 0.400 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2024 | 425 | 0.400 |
Why?
|
| Liver Cirrhosis | 2 | 2017 | 908 | 0.400 |
Why?
|
| Algorithms | 6 | 2014 | 1679 | 0.400 |
Why?
|
| Prognosis | 16 | 2024 | 4934 | 0.400 |
Why?
|
| Leiomyoma | 2 | 2024 | 74 | 0.390 |
Why?
|
| Carcinoma, Medullary | 2 | 2025 | 17 | 0.380 |
Why?
|
| Sequence Alignment | 4 | 2014 | 585 | 0.380 |
Why?
|
| Cell Cycle Proteins | 8 | 2021 | 699 | 0.380 |
Why?
|
| Sequence Analysis, RNA | 10 | 2024 | 418 | 0.370 |
Why?
|
| Alleles | 6 | 2025 | 1671 | 0.360 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1175 | 0.360 |
Why?
|
| Ovarian Neoplasms | 4 | 2019 | 453 | 0.360 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2025 | 838 | 0.360 |
Why?
|
| p21-Activated Kinases | 3 | 2021 | 56 | 0.360 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2024 | 280 | 0.350 |
Why?
|
| Neoplasms | 9 | 2024 | 2959 | 0.350 |
Why?
|
| RNA-Binding Proteins | 7 | 2018 | 545 | 0.350 |
Why?
|
| Hyperglycemia | 2 | 2025 | 233 | 0.350 |
Why?
|
| Genomics | 9 | 2026 | 1623 | 0.350 |
Why?
|
| Prostate | 3 | 2018 | 408 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2021 | 479 | 0.340 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 2 | 2022 | 19 | 0.340 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2023 | 407 | 0.340 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2026 | 70 | 0.340 |
Why?
|
| Mitochondria | 3 | 2026 | 761 | 0.340 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2021 | 606 | 0.340 |
Why?
|
| Kidney | 1 | 2017 | 1286 | 0.340 |
Why?
|
| Nuclear Receptor Coactivator 3 | 4 | 2018 | 257 | 0.340 |
Why?
|
| Azepines | 5 | 2020 | 62 | 0.330 |
Why?
|
| Tumor Escape | 2 | 2023 | 62 | 0.330 |
Why?
|
| RANK Ligand | 2 | 2022 | 52 | 0.330 |
Why?
|
| Microtubules | 2 | 2021 | 125 | 0.330 |
Why?
|
| beta Catenin | 4 | 2020 | 204 | 0.330 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 674 | 0.330 |
Why?
|
| Disease Progression | 11 | 2026 | 2203 | 0.330 |
Why?
|
| Neoplasm Metastasis | 5 | 2021 | 701 | 0.330 |
Why?
|
| Smoke | 3 | 2026 | 81 | 0.320 |
Why?
|
| Glutamine | 5 | 2024 | 204 | 0.320 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2021 | 231 | 0.320 |
Why?
|
| Animals, Newborn | 7 | 2023 | 1017 | 0.320 |
Why?
|
| Pyrazoles | 5 | 2021 | 356 | 0.320 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2015 | 200 | 0.310 |
Why?
|
| Cellular Senescence | 5 | 2026 | 216 | 0.310 |
Why?
|
| Infertility, Male | 4 | 2020 | 296 | 0.310 |
Why?
|
| Endocrine Disruptors | 4 | 2024 | 55 | 0.310 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2016 | 326 | 0.310 |
Why?
|
| Transcriptional Activation | 4 | 2019 | 417 | 0.310 |
Why?
|
| Mice, Transgenic | 11 | 2025 | 2345 | 0.310 |
Why?
|
| Chromatin | 8 | 2025 | 501 | 0.310 |
Why?
|
| Inflammation | 6 | 2025 | 1491 | 0.310 |
Why?
|
| Homeodomain Proteins | 5 | 2020 | 569 | 0.300 |
Why?
|
| Genetic Variation | 5 | 2024 | 1558 | 0.300 |
Why?
|
| Cell Nucleus | 3 | 2021 | 562 | 0.300 |
Why?
|
| Cells, Cultured | 12 | 2022 | 2908 | 0.300 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2025 | 258 | 0.290 |
Why?
|
| Alternative Splicing | 4 | 2026 | 309 | 0.290 |
Why?
|
| Response Elements | 2 | 2026 | 104 | 0.290 |
Why?
|
| Genome-Wide Association Study | 10 | 2024 | 1841 | 0.290 |
Why?
|
| ErbB Receptors | 3 | 2021 | 295 | 0.290 |
Why?
|
| Neoplasm Invasiveness | 9 | 2021 | 632 | 0.290 |
Why?
|
| Mutation, Missense | 3 | 2025 | 934 | 0.290 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2020 | 69 | 0.290 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2019 | 229 | 0.290 |
Why?
|
| Gastrulation | 2 | 2026 | 27 | 0.280 |
Why?
|
| Melanoma | 3 | 2021 | 920 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2023 | 2850 | 0.280 |
Why?
|
| Down-Regulation | 6 | 2020 | 654 | 0.280 |
Why?
|
| Lipopolysaccharides | 3 | 2024 | 303 | 0.280 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 564 | 0.280 |
Why?
|
| Spermatogenesis | 3 | 2020 | 168 | 0.280 |
Why?
|
| Adult | 22 | 2026 | 31274 | 0.280 |
Why?
|
| Proteolysis | 5 | 2021 | 194 | 0.280 |
Why?
|
| CRISPR-Cas Systems | 6 | 2024 | 317 | 0.280 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2021 | 189 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2020 | 623 | 0.280 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2025 | 345 | 0.280 |
Why?
|
| Rhabdomyosarcoma | 2 | 2022 | 228 | 0.270 |
Why?
|
| Jejunum | 2 | 2025 | 123 | 0.270 |
Why?
|
| Phosphorylation | 10 | 2024 | 1571 | 0.270 |
Why?
|
| Tamoxifen | 3 | 2020 | 351 | 0.270 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2020 | 29 | 0.270 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 197 | 0.270 |
Why?
|
| Binding Sites | 6 | 2019 | 1144 | 0.270 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2025 | 31 | 0.270 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2022 | 284 | 0.260 |
Why?
|
| Fertility | 2 | 2020 | 258 | 0.260 |
Why?
|
| Aminopyridines | 3 | 2026 | 63 | 0.260 |
Why?
|
| Real-Time Polymerase Chain Reaction | 6 | 2020 | 529 | 0.260 |
Why?
|
| Up-Regulation | 4 | 2022 | 829 | 0.260 |
Why?
|
| Mice, Nude | 8 | 2021 | 708 | 0.260 |
Why?
|
| Protein Isoforms | 7 | 2026 | 418 | 0.250 |
Why?
|
| Ubiquitination | 4 | 2023 | 174 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2026 | 989 | 0.250 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2023 | 1003 | 0.250 |
Why?
|
| Disease | 3 | 2019 | 124 | 0.250 |
Why?
|
| Pinocytosis | 1 | 2026 | 12 | 0.240 |
Why?
|
| RNA, Small Interfering | 7 | 2018 | 663 | 0.240 |
Why?
|
| Amiloride | 1 | 2026 | 31 | 0.240 |
Why?
|
| Androgen Antagonists | 3 | 2023 | 109 | 0.240 |
Why?
|
| HEK293 Cells | 9 | 2021 | 814 | 0.240 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2026 | 17 | 0.240 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2026 | 28 | 0.240 |
Why?
|
| Hypothalamus | 3 | 2022 | 203 | 0.240 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2026 | 17 | 0.240 |
Why?
|
| Immune Tolerance | 2 | 2024 | 153 | 0.240 |
Why?
|
| Lymphoma, Mantle-Cell | 2 | 2017 | 42 | 0.240 |
Why?
|
| Sulfatases | 1 | 2026 | 47 | 0.240 |
Why?
|
| Endothelial Cells | 4 | 2026 | 518 | 0.240 |
Why?
|
| Drug Synergism | 4 | 2019 | 237 | 0.230 |
Why?
|
| Pneumonia | 2 | 2022 | 342 | 0.230 |
Why?
|
| Gamma Rays | 1 | 2025 | 42 | 0.230 |
Why?
|
| Centrosome | 1 | 2025 | 28 | 0.230 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2025 | 70 | 0.230 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2025 | 43 | 0.230 |
Why?
|
| Mice, SCID | 8 | 2019 | 580 | 0.230 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2026 | 147 | 0.230 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 43 | 0.230 |
Why?
|
| Nodal Protein | 1 | 2025 | 28 | 0.230 |
Why?
|
| Photons | 1 | 2025 | 62 | 0.230 |
Why?
|
| Carbon | 1 | 2026 | 101 | 0.230 |
Why?
|
| CA-125 Antigen | 1 | 2025 | 14 | 0.230 |
Why?
|
| Protons | 1 | 2025 | 98 | 0.230 |
Why?
|
| Base Sequence | 9 | 2018 | 2746 | 0.230 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2017 | 161 | 0.230 |
Why?
|
| Heparan Sulfate Proteoglycans | 2 | 2026 | 20 | 0.230 |
Why?
|
| Blood Glucose | 3 | 2025 | 1107 | 0.220 |
Why?
|
| Ultraviolet Rays | 3 | 2020 | 191 | 0.220 |
Why?
|
| Alagille Syndrome | 1 | 2025 | 54 | 0.220 |
Why?
|
| Gene Expression | 5 | 2020 | 1488 | 0.220 |
Why?
|
| Middle Aged | 19 | 2026 | 28510 | 0.220 |
Why?
|
| Oncogenes | 3 | 2021 | 164 | 0.220 |
Why?
|
| DNA Replication | 3 | 2026 | 357 | 0.220 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2024 | 26 | 0.220 |
Why?
|
| Spermatozoa | 3 | 2020 | 254 | 0.220 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2016 | 208 | 0.220 |
Why?
|
| Receptors, Immunologic | 1 | 2025 | 125 | 0.220 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 64 | 0.220 |
Why?
|
| Homeostasis | 4 | 2020 | 715 | 0.220 |
Why?
|
| Pentose Phosphate Pathway | 3 | 2019 | 44 | 0.220 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 43 | 0.210 |
Why?
|
| Cytokines | 4 | 2025 | 1339 | 0.210 |
Why?
|
| SMARCB1 Protein | 2 | 2025 | 42 | 0.210 |
Why?
|
| Myocardium | 5 | 2020 | 865 | 0.210 |
Why?
|
| Glioblastoma | 2 | 2019 | 349 | 0.210 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2025 | 126 | 0.210 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2024 | 26 | 0.210 |
Why?
|
| Pyrimidines | 5 | 2026 | 450 | 0.210 |
Why?
|
| Wnt Proteins | 3 | 2021 | 196 | 0.210 |
Why?
|
| Macrophages | 2 | 2025 | 653 | 0.210 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2021 | 301 | 0.210 |
Why?
|
| Immunity | 2 | 2022 | 179 | 0.210 |
Why?
|
| Mental Disorders | 2 | 2025 | 895 | 0.210 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2026 | 148 | 0.210 |
Why?
|
| RNA | 4 | 2022 | 517 | 0.210 |
Why?
|
| Databases, Genetic | 6 | 2018 | 505 | 0.210 |
Why?
|
| Histone Demethylases | 2 | 2021 | 43 | 0.210 |
Why?
|
| Aging | 2 | 2026 | 1252 | 0.210 |
Why?
|
| Feces | 2 | 2025 | 723 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2022 | 357 | 0.210 |
Why?
|
| Phagocytosis | 1 | 2025 | 189 | 0.210 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2024 | 34 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2026 | 856 | 0.210 |
Why?
|
| Myometrium | 1 | 2024 | 47 | 0.210 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2015 | 162 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2025 | 93 | 0.210 |
Why?
|
| Neuralgia | 1 | 2024 | 50 | 0.210 |
Why?
|
| Protein Phosphatase 2C | 1 | 2024 | 59 | 0.210 |
Why?
|
| Sensory Receptor Cells | 1 | 2024 | 59 | 0.210 |
Why?
|
| Pulmonary Fibrosis | 1 | 2025 | 114 | 0.210 |
Why?
|
| Aurora Kinase A | 2 | 2021 | 36 | 0.210 |
Why?
|
| Haploinsufficiency | 2 | 2025 | 262 | 0.210 |
Why?
|
| Diet, High-Fat | 3 | 2025 | 264 | 0.210 |
Why?
|
| Acrylamides | 2 | 2021 | 27 | 0.210 |
Why?
|
| Gene Silencing | 4 | 2021 | 230 | 0.200 |
Why?
|
| Ipilimumab | 2 | 2021 | 62 | 0.200 |
Why?
|
| DNA Helicases | 1 | 2025 | 233 | 0.200 |
Why?
|
| Intestinal Polyposis | 1 | 2023 | 17 | 0.200 |
Why?
|
| Precancerous Conditions | 2 | 2017 | 280 | 0.200 |
Why?
|
| Case-Control Studies | 9 | 2025 | 3418 | 0.200 |
Why?
|
| Personality | 1 | 2025 | 112 | 0.200 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2024 | 74 | 0.200 |
Why?
|
| Escherichia coli | 4 | 2023 | 984 | 0.200 |
Why?
|
| Chromosome Aberrations | 2 | 2020 | 576 | 0.200 |
Why?
|
| Phenotype | 11 | 2025 | 4483 | 0.200 |
Why?
|
| Biomarkers | 5 | 2025 | 3400 | 0.200 |
Why?
|
| Genes, Neoplasm | 2 | 2018 | 80 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 1325 | 0.200 |
Why?
|
| Tumor Microenvironment | 6 | 2025 | 691 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 8 | 2024 | 1213 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 3417 | 0.200 |
Why?
|
| Cholestasis | 1 | 2025 | 165 | 0.200 |
Why?
|
| Adrenomedullin | 1 | 2024 | 82 | 0.200 |
Why?
|
| Proteome | 3 | 2025 | 288 | 0.200 |
Why?
|
| Microbiota | 2 | 2022 | 445 | 0.200 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2023 | 14 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 6 | 2021 | 378 | 0.190 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 104 | 0.190 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2020 | 151 | 0.190 |
Why?
|
| Oncogene Proteins | 2 | 2015 | 136 | 0.190 |
Why?
|
| Hedgehog Proteins | 1 | 2024 | 203 | 0.190 |
Why?
|
| Glutamic Acid | 1 | 2024 | 210 | 0.190 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 230 | 0.190 |
Why?
|
| STAT1 Transcription Factor | 2 | 2020 | 75 | 0.190 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2022 | 16 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 3 | 2023 | 456 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2025 | 6494 | 0.190 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 125 | 0.190 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 193 | 0.190 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2020 | 274 | 0.190 |
Why?
|
| Whole Genome Sequencing | 2 | 2025 | 358 | 0.190 |
Why?
|
| Keratinocytes | 3 | 2022 | 73 | 0.190 |
Why?
|
| Metagenome | 3 | 2012 | 142 | 0.190 |
Why?
|
| Pyrroles | 2 | 2021 | 184 | 0.190 |
Why?
|
| Evolution, Molecular | 5 | 2015 | 656 | 0.180 |
Why?
|
| Aged | 14 | 2026 | 20968 | 0.180 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2022 | 41 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2015 | 245 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 4 | 2021 | 385 | 0.180 |
Why?
|
| Biliary Atresia | 1 | 2025 | 220 | 0.180 |
Why?
|
| Mice, Inbred NOD | 6 | 2019 | 301 | 0.180 |
Why?
|
| Stem Cells | 3 | 2021 | 711 | 0.180 |
Why?
|
| Personality Disorders | 1 | 2025 | 171 | 0.180 |
Why?
|
| Lymphoma | 2 | 2016 | 331 | 0.180 |
Why?
|
| Intestine, Small | 1 | 2024 | 288 | 0.180 |
Why?
|
| Urinary Bladder | 2 | 2023 | 220 | 0.180 |
Why?
|
| DNA Adducts | 2 | 2019 | 71 | 0.180 |
Why?
|
| Environmental Exposure | 3 | 2025 | 291 | 0.180 |
Why?
|
| Tail | 1 | 2021 | 11 | 0.180 |
Why?
|
| Animal Fins | 1 | 2021 | 2 | 0.180 |
Why?
|
| Doxycycline | 1 | 2022 | 111 | 0.180 |
Why?
|
| DNA Transposable Elements | 1 | 2023 | 182 | 0.180 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2022 | 64 | 0.180 |
Why?
|
| RNA Splicing | 2 | 2021 | 234 | 0.180 |
Why?
|
| Primary Graft Dysfunction | 1 | 2022 | 41 | 0.180 |
Why?
|
| Benzimidazoles | 2 | 2026 | 155 | 0.180 |
Why?
|
| Carcinogens | 2 | 2023 | 128 | 0.180 |
Why?
|
| Adipose Tissue | 2 | 2025 | 496 | 0.180 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 130 | 0.180 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 2021 | 2 | 0.180 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2021 | 7 | 0.180 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2021 | 9 | 0.180 |
Why?
|
| Proteoglycans | 1 | 2021 | 77 | 0.180 |
Why?
|
| Pyridines | 2 | 2020 | 258 | 0.180 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2021 | 99 | 0.180 |
Why?
|
| Gonadal Hormones | 1 | 2021 | 3 | 0.180 |
Why?
|
| Endometriosis | 1 | 2024 | 176 | 0.180 |
Why?
|
| Regeneration | 2 | 2021 | 231 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2022 | 114 | 0.170 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 15 | 0.170 |
Why?
|
| Osteocalcin | 1 | 2021 | 45 | 0.170 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2020 | 235 | 0.170 |
Why?
|
| Sex Chromosomes | 1 | 2021 | 29 | 0.170 |
Why?
|
| CA-19-9 Antigen | 1 | 2021 | 11 | 0.170 |
Why?
|
| Phosphoramide Mustards | 1 | 2021 | 2 | 0.170 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 466 | 0.170 |
Why?
|
| Human papillomavirus 16 | 1 | 2022 | 97 | 0.170 |
Why?
|
| Amino Acids | 1 | 2024 | 566 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 306 | 0.170 |
Why?
|
| Retinoids | 1 | 2021 | 29 | 0.170 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2021 | 50 | 0.170 |
Why?
|
| Metagenomics | 2 | 2012 | 115 | 0.170 |
Why?
|
| Phenylketonurias | 1 | 2021 | 21 | 0.170 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2021 | 34 | 0.170 |
Why?
|
| Friedreich Ataxia | 1 | 2021 | 30 | 0.170 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2021 | 105 | 0.170 |
Why?
|
| Asthma | 2 | 2025 | 926 | 0.170 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2023 | 82 | 0.170 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2021 | 20 | 0.170 |
Why?
|
| Triazoles | 3 | 2020 | 143 | 0.170 |
Why?
|
| RNA Interference | 6 | 2020 | 492 | 0.170 |
Why?
|
| Systems Biology | 1 | 2021 | 60 | 0.170 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 2 | 2019 | 79 | 0.170 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 51 | 0.170 |
Why?
|
| Quality Control | 1 | 2021 | 116 | 0.170 |
Why?
|
| Arachis | 1 | 2021 | 65 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 131 | 0.170 |
Why?
|
| Adenine | 3 | 2021 | 122 | 0.170 |
Why?
|
| Nitroimidazoles | 1 | 2021 | 47 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2019 | 172 | 0.170 |
Why?
|
| GTPase-Activating Proteins | 2 | 2019 | 86 | 0.170 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2021 | 90 | 0.160 |
Why?
|
| Lipid Metabolism | 5 | 2024 | 373 | 0.160 |
Why?
|
| Virus Replication | 4 | 2026 | 597 | 0.160 |
Why?
|
| Survival Rate | 7 | 2020 | 2145 | 0.160 |
Why?
|
| Tobacco Products | 2 | 2019 | 60 | 0.160 |
Why?
|
| Pyrimidinones | 2 | 2018 | 64 | 0.160 |
Why?
|
| Cells | 1 | 2020 | 20 | 0.160 |
Why?
|
| Adipocytes, Brown | 1 | 2020 | 27 | 0.160 |
Why?
|
| Cilia | 1 | 2021 | 79 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2022 | 125 | 0.160 |
Why?
|
| Estrogens | 3 | 2020 | 432 | 0.160 |
Why?
|
| Reading | 1 | 2021 | 76 | 0.160 |
Why?
|
| PPAR gamma | 2 | 2020 | 87 | 0.160 |
Why?
|
| Peanut Hypersensitivity | 1 | 2021 | 73 | 0.160 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 129 | 0.160 |
Why?
|
| Running | 1 | 2020 | 32 | 0.160 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8570 | 0.160 |
Why?
|
| Quinolines | 1 | 2021 | 119 | 0.160 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Protein Binding | 6 | 2021 | 1660 | 0.160 |
Why?
|
| Thalidomide | 2 | 2017 | 39 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2021 | 427 | 0.160 |
Why?
|
| Bacterial Adhesion | 1 | 2020 | 104 | 0.160 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2020 | 45 | 0.160 |
Why?
|
| Calcitriol | 1 | 2020 | 64 | 0.160 |
Why?
|
| Tissue Array Analysis | 4 | 2021 | 135 | 0.160 |
Why?
|
| Desensitization, Immunologic | 1 | 2021 | 105 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2020 | 33 | 0.160 |
Why?
|
| RNA, Antisense | 1 | 2020 | 34 | 0.160 |
Why?
|
| Neoplasm Staging | 6 | 2021 | 1307 | 0.160 |
Why?
|
| Adipocytes | 3 | 2020 | 176 | 0.160 |
Why?
|
| Copper-transporting ATPases | 1 | 2020 | 27 | 0.160 |
Why?
|
| Epididymis | 1 | 2020 | 64 | 0.160 |
Why?
|
| Estradiol | 3 | 2020 | 477 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 231 | 0.160 |
Why?
|
| Inactivation, Metabolic | 1 | 2019 | 26 | 0.160 |
Why?
|
| Filamins | 1 | 2019 | 26 | 0.160 |
Why?
|
| Anilides | 1 | 2020 | 51 | 0.160 |
Why?
|
| ras Proteins | 1 | 2020 | 146 | 0.150 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 2 | 2016 | 9 | 0.150 |
Why?
|
| Thiophenes | 1 | 2020 | 68 | 0.150 |
Why?
|
| Prodrugs | 1 | 2020 | 56 | 0.150 |
Why?
|
| Imidazoles | 1 | 2021 | 220 | 0.150 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2019 | 41 | 0.150 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 7 | 0.150 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2020 | 36 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2022 | 484 | 0.150 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 418 | 0.150 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2019 | 35 | 0.150 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2016 | 23 | 0.150 |
Why?
|
| Interferons | 1 | 2020 | 136 | 0.150 |
Why?
|
| GATA2 Transcription Factor | 2 | 2021 | 46 | 0.150 |
Why?
|
| Sumoylation | 1 | 2019 | 40 | 0.150 |
Why?
|
| Vitamins | 1 | 2020 | 114 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 20 | 0.150 |
Why?
|
| Spheroids, Cellular | 2 | 2016 | 59 | 0.150 |
Why?
|
| Cytosol | 1 | 2019 | 139 | 0.150 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2019 | 31 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 231 | 0.150 |
Why?
|
| Salivary Glands | 1 | 2019 | 34 | 0.150 |
Why?
|
| Complement C1q | 1 | 2019 | 18 | 0.150 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2019 | 38 | 0.150 |
Why?
|
| Sarcoma | 1 | 2022 | 212 | 0.150 |
Why?
|
| Mutation Rate | 3 | 2018 | 68 | 0.150 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 233 | 0.150 |
Why?
|
| Longevity | 1 | 2021 | 177 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 327 | 0.150 |
Why?
|
| Environmental Pollution | 1 | 2019 | 17 | 0.150 |
Why?
|
| Rotavirus Infections | 1 | 2021 | 283 | 0.150 |
Why?
|
| Interleukin-2 | 1 | 2020 | 236 | 0.150 |
Why?
|
| Neoplasm Transplantation | 5 | 2021 | 358 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 249 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2019 | 112 | 0.150 |
Why?
|
| Breast | 2 | 2018 | 216 | 0.150 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 28 | 0.150 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2019 | 20 | 0.150 |
Why?
|
| POU Domain Factors | 1 | 2018 | 8 | 0.150 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2019 | 40 | 0.150 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 50 | 0.150 |
Why?
|
| Leukocytes | 1 | 2020 | 207 | 0.150 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 81 | 0.150 |
Why?
|
| Androgens | 5 | 2023 | 265 | 0.150 |
Why?
|
| Germ Cells | 3 | 2016 | 201 | 0.150 |
Why?
|
| Granulosa Cells | 1 | 2019 | 140 | 0.150 |
Why?
|
| APOBEC Deaminases | 1 | 2018 | 7 | 0.140 |
Why?
|
| Allelic Imbalance | 1 | 2018 | 11 | 0.140 |
Why?
|
| Circadian Clocks | 2 | 2016 | 86 | 0.140 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 166 | 0.140 |
Why?
|
| Pyruvic Acid | 1 | 2018 | 35 | 0.140 |
Why?
|
| Cytosine Deaminase | 1 | 2018 | 15 | 0.140 |
Why?
|
| Cell Communication | 1 | 2019 | 186 | 0.140 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2018 | 10 | 0.140 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2019 | 62 | 0.140 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 122 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2016 | 87 | 0.140 |
Why?
|
| Aortic Rupture | 1 | 2019 | 112 | 0.140 |
Why?
|
| Nitric Oxide | 1 | 2021 | 467 | 0.140 |
Why?
|
| Insulin | 2 | 2021 | 1146 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 1307 | 0.140 |
Why?
|
| Infertility, Female | 1 | 2019 | 147 | 0.140 |
Why?
|
| Glycolysis | 4 | 2022 | 174 | 0.140 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2018 | 26 | 0.140 |
Why?
|
| Escherichia coli Infections | 1 | 2020 | 194 | 0.140 |
Why?
|
| Argonaute Proteins | 2 | 2016 | 29 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 235 | 0.140 |
Why?
|
| RNA, Messenger | 7 | 2020 | 2558 | 0.140 |
Why?
|
| Actins | 1 | 2020 | 314 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2019 | 95 | 0.140 |
Why?
|
| Ascaris lumbricoides | 1 | 2018 | 19 | 0.140 |
Why?
|
| Schistosoma haematobium | 1 | 2018 | 17 | 0.140 |
Why?
|
| Emphysema | 1 | 2019 | 67 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2021 | 326 | 0.140 |
Why?
|
| Subcutaneous Fat | 1 | 2018 | 34 | 0.140 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 731 | 0.140 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 22 | 0.140 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2018 | 22 | 0.140 |
Why?
|
| Embryonic Stem Cells | 3 | 2015 | 159 | 0.140 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 385 | 0.140 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2018 | 99 | 0.140 |
Why?
|
| Escherichia coli Proteins | 1 | 2020 | 310 | 0.140 |
Why?
|
| Anxiety | 2 | 2022 | 1009 | 0.140 |
Why?
|
| RNAi Therapeutics | 1 | 2018 | 17 | 0.140 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 31 | 0.140 |
Why?
|
| Schistosomiasis | 1 | 2018 | 52 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2021 | 770 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2020 | 414 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2018 | 88 | 0.140 |
Why?
|
| Naphthalimides | 1 | 2017 | 7 | 0.140 |
Why?
|
| Oocytes | 1 | 2019 | 273 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 81 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2018 | 31 | 0.130 |
Why?
|
| Lung Transplantation | 1 | 2022 | 354 | 0.130 |
Why?
|
| Brain | 4 | 2021 | 3224 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 1272 | 0.130 |
Why?
|
| Myotonic Dystrophy | 1 | 2018 | 74 | 0.130 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 1 | 2018 | 46 | 0.130 |
Why?
|
| Heart Failure | 2 | 2022 | 2317 | 0.130 |
Why?
|
| Interferon-gamma | 4 | 2021 | 539 | 0.130 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 5 | 0.130 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2017 | 39 | 0.130 |
Why?
|
| BCG Vaccine | 1 | 2018 | 110 | 0.130 |
Why?
|
| TATA-Box Binding Protein | 1 | 2017 | 29 | 0.130 |
Why?
|
| Mutagens | 1 | 2017 | 47 | 0.130 |
Why?
|
| Autophagy | 2 | 2020 | 422 | 0.130 |
Why?
|
| Th1 Cells | 1 | 2018 | 156 | 0.130 |
Why?
|
| Twins, Monozygotic | 1 | 2018 | 124 | 0.130 |
Why?
|
| Transfection | 5 | 2019 | 947 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 635 | 0.130 |
Why?
|
| Models, Biological | 6 | 2020 | 1392 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2016 | 306 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 39 | 0.130 |
Why?
|
| Ascariasis | 1 | 2018 | 77 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 1 | 2017 | 51 | 0.130 |
Why?
|
| Hyperthermia, Induced | 1 | 2017 | 56 | 0.130 |
Why?
|
| Peroxisomal Disorders | 1 | 2017 | 17 | 0.130 |
Why?
|
| Peroxisomes | 1 | 2017 | 40 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 201 | 0.130 |
Why?
|
| Receptors, Calcitriol | 1 | 2017 | 60 | 0.130 |
Why?
|
| Smoking | 2 | 2023 | 926 | 0.130 |
Why?
|
| Batch Cell Culture Techniques | 1 | 2016 | 5 | 0.130 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 395 | 0.130 |
Why?
|
| Gene Editing | 1 | 2019 | 230 | 0.120 |
Why?
|
| Phospholipids | 1 | 2017 | 103 | 0.120 |
Why?
|
| Cell Survival | 5 | 2017 | 840 | 0.120 |
Why?
|
| Keratosis, Actinic | 1 | 2016 | 15 | 0.120 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2014 | 55 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 587 | 0.120 |
Why?
|
| Cell Line | 5 | 2022 | 2571 | 0.120 |
Why?
|
| Carrier Proteins | 3 | 2017 | 1018 | 0.120 |
Why?
|
| Ribonuclease III | 2 | 2014 | 103 | 0.120 |
Why?
|
| X Chromosome | 2 | 2014 | 329 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 57 | 0.120 |
Why?
|
| N-Myc Proto-Oncogene Protein | 4 | 2022 | 58 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 136 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 510 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2019 | 438 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 755 | 0.120 |
Why?
|
| Immunity, Innate | 3 | 2024 | 410 | 0.120 |
Why?
|
| Neoplasm Grading | 4 | 2019 | 274 | 0.120 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 80 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 125 | 0.120 |
Why?
|
| Methyltransferases | 1 | 2016 | 77 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 91 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2016 | 92 | 0.120 |
Why?
|
| Annexin A1 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Printing, Three-Dimensional | 1 | 2016 | 87 | 0.120 |
Why?
|
| Maternal Behavior | 1 | 2016 | 70 | 0.120 |
Why?
|
| Cell Cycle | 4 | 2020 | 595 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2015 | 11 | 0.120 |
Why?
|
| Receptors, Steroid | 1 | 2016 | 171 | 0.120 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2015 | 8 | 0.110 |
Why?
|
| Endometrium | 1 | 2018 | 281 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 188 | 0.110 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2015 | 38 | 0.110 |
Why?
|
| DNA Copy Number Variations | 3 | 2020 | 1028 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 69 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 333 | 0.110 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 102 | 0.110 |
Why?
|
| Sulfites | 4 | 2018 | 27 | 0.110 |
Why?
|
| Synteny | 1 | 2015 | 69 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2020 | 397 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 675 | 0.110 |
Why?
|
| Embryo, Nonmammalian | 2 | 2026 | 139 | 0.110 |
Why?
|
| MCF-7 Cells | 4 | 2016 | 209 | 0.110 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2014 | 13 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 1092 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 650 | 0.110 |
Why?
|
| Placenta | 1 | 2019 | 513 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 50 | 0.110 |
Why?
|
| Premature Birth | 1 | 2019 | 423 | 0.110 |
Why?
|
| Lysosomes | 1 | 2016 | 269 | 0.110 |
Why?
|
| Sezary Syndrome | 1 | 2014 | 13 | 0.110 |
Why?
|
| Tissue Engineering | 1 | 2016 | 164 | 0.110 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2014 | 32 | 0.110 |
Why?
|
| Genomic Imprinting | 1 | 2015 | 125 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 265 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 271 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 567 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2014 | 6 | 0.110 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 62 | 0.110 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 135 | 0.110 |
Why?
|
| Triglycerides | 1 | 2017 | 605 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 879 | 0.110 |
Why?
|
| Machine Learning | 3 | 2025 | 384 | 0.110 |
Why?
|
| RNA Stability | 1 | 2014 | 75 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 28 | 0.100 |
Why?
|
| Child | 7 | 2025 | 26219 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2012 | 389 | 0.100 |
Why?
|
| NAD | 1 | 2014 | 50 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 3 | 2022 | 213 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 331 | 0.100 |
Why?
|
| Tumor Burden | 3 | 2021 | 240 | 0.100 |
Why?
|
| Ovary | 2 | 2021 | 356 | 0.100 |
Why?
|
| Datasets as Topic | 3 | 2021 | 103 | 0.100 |
Why?
|
| Neuroglia | 1 | 2015 | 222 | 0.100 |
Why?
|
| Oxidative Stress | 3 | 2025 | 803 | 0.100 |
Why?
|
| Veterans | 1 | 2025 | 1792 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 3062 | 0.100 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2013 | 10 | 0.100 |
Why?
|
| Methylation | 3 | 2021 | 197 | 0.100 |
Why?
|
| Osteocytes | 1 | 2013 | 19 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 192 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2022 | 5091 | 0.100 |
Why?
|
| Tretinoin | 1 | 2013 | 95 | 0.100 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 25 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2026 | 146 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2018 | 502 | 0.100 |
Why?
|
| Motor Activity | 1 | 2016 | 500 | 0.100 |
Why?
|
| Heart | 1 | 2017 | 666 | 0.100 |
Why?
|
| Meiosis | 2 | 2010 | 110 | 0.100 |
Why?
|
| Time Factors | 6 | 2021 | 6243 | 0.090 |
Why?
|
| Gastrointestinal Tract | 2 | 2012 | 224 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 232 | 0.090 |
Why?
|
| Haplotypes | 1 | 2014 | 522 | 0.090 |
Why?
|
| Acetylation | 2 | 2025 | 182 | 0.090 |
Why?
|
| Chromatography, Liquid | 3 | 2019 | 239 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 162 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2022 | 449 | 0.090 |
Why?
|
| A549 Cells | 2 | 2022 | 49 | 0.090 |
Why?
|
| Coculture Techniques | 2 | 2025 | 232 | 0.090 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2012 | 217 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 1002 | 0.090 |
Why?
|
| Drosophila Proteins | 3 | 2017 | 785 | 0.090 |
Why?
|
| Piperazines | 2 | 2026 | 270 | 0.090 |
Why?
|
| Piperidines | 3 | 2021 | 230 | 0.090 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2026 | 178 | 0.090 |
Why?
|
| Finches | 1 | 2011 | 6 | 0.090 |
Why?
|
| Nucleotides | 3 | 2019 | 90 | 0.090 |
Why?
|
| Vocalization, Animal | 1 | 2011 | 19 | 0.090 |
Why?
|
| Cellular Reprogramming | 2 | 2025 | 128 | 0.090 |
Why?
|
| Prosencephalon | 1 | 2011 | 41 | 0.090 |
Why?
|
| Auditory Cortex | 1 | 2011 | 28 | 0.090 |
Why?
|
| Adolescent | 3 | 2025 | 20835 | 0.080 |
Why?
|
| E1A-Associated p300 Protein | 2 | 2022 | 50 | 0.080 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 517 | 0.080 |
Why?
|
| Epidermis | 2 | 2024 | 63 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 6784 | 0.080 |
Why?
|
| Mice, Obese | 2 | 2022 | 72 | 0.080 |
Why?
|
| Indoles | 2 | 2024 | 201 | 0.080 |
Why?
|
| Vagina | 1 | 2012 | 207 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 98 | 0.080 |
Why?
|
| Rats | 3 | 2023 | 3413 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2012 | 317 | 0.080 |
Why?
|
| Epithelium | 2 | 2022 | 339 | 0.080 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 105 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2014 | 1053 | 0.080 |
Why?
|
| Sex Factors | 3 | 2023 | 1342 | 0.080 |
Why?
|
| Retroelements | 1 | 2009 | 42 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 3 | 2017 | 151 | 0.080 |
Why?
|
| Genetic Loci | 3 | 2018 | 356 | 0.080 |
Why?
|
| Inpatients | 2 | 2025 | 546 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 439 | 0.070 |
Why?
|
| Thymus Gland | 2 | 2022 | 100 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 850 | 0.070 |
Why?
|
| Autophagy-Related Proteins | 2 | 2020 | 37 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 2 | 2022 | 324 | 0.070 |
Why?
|
| Myosin Heavy Chains | 2 | 2020 | 75 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2021 | 340 | 0.070 |
Why?
|
| Chromosome Breakage | 1 | 2008 | 156 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2017 | 1007 | 0.070 |
Why?
|
| Fibrosis | 2 | 2021 | 419 | 0.070 |
Why?
|
| Adiposity | 2 | 2020 | 208 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1218 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2022 | 93 | 0.070 |
Why?
|
| Cell Lineage | 3 | 2015 | 346 | 0.070 |
Why?
|
| Species Specificity | 2 | 2022 | 490 | 0.070 |
Why?
|
| Leukemia | 2 | 2024 | 375 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 2 | 2021 | 181 | 0.070 |
Why?
|
| Transcription Initiation Site | 2 | 2017 | 32 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2022 | 899 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2021 | 298 | 0.070 |
Why?
|
| Gambia | 2 | 2019 | 26 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2021 | 157 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2019 | 331 | 0.070 |
Why?
|
| Hypoglycemic Agents | 2 | 2022 | 475 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 363 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 627 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2023 | 451 | 0.060 |
Why?
|
| Nitriles | 2 | 2018 | 162 | 0.060 |
Why?
|
| Exome | 1 | 2012 | 1077 | 0.060 |
Why?
|
| Multigene Family | 2 | 2021 | 291 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2020 | 224 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2018 | 49 | 0.060 |
Why?
|
| Pyridones | 2 | 2019 | 149 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 1165 | 0.060 |
Why?
|
| Phthalazines | 1 | 2026 | 20 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 788 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2026 | 29 | 0.060 |
Why?
|
| Entropy | 1 | 2026 | 28 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2026 | 125 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 1076 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2026 | 41 | 0.060 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2026 | 35 | 0.060 |
Why?
|
| Nucleotide Motifs | 1 | 2026 | 49 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2019 | 586 | 0.060 |
Why?
|
| Bleomycin | 1 | 2026 | 118 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3488 | 0.060 |
Why?
|
| Genes, Intracisternal A-Particle | 1 | 2025 | 4 | 0.060 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2025 | 32 | 0.060 |
Why?
|
| Spirometry | 1 | 2025 | 92 | 0.060 |
Why?
|
| Chemokines | 1 | 2026 | 124 | 0.060 |
Why?
|
| Chromosome Segregation | 1 | 2025 | 68 | 0.060 |
Why?
|
| Gastrula | 1 | 2025 | 23 | 0.060 |
Why?
|
| Neural Plate | 1 | 2025 | 13 | 0.060 |
Why?
|
| Ectoderm | 1 | 2025 | 31 | 0.060 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2025 | 30 | 0.060 |
Why?
|
| Trialkyltin Compounds | 1 | 2024 | 7 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2025 | 224 | 0.060 |
Why?
|
| Receptors, Opioid, delta | 1 | 2024 | 12 | 0.060 |
Why?
|
| Mesoderm | 1 | 2025 | 106 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 364 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2025 | 112 | 0.050 |
Why?
|
| Succinic Acid | 1 | 2024 | 13 | 0.050 |
Why?
|
| Succinates | 1 | 2024 | 15 | 0.050 |
Why?
|
| Mitosis | 1 | 2025 | 185 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2022 | 419 | 0.050 |
Why?
|
| Body Patterning | 1 | 2025 | 128 | 0.050 |
Why?
|
| Chromosomes, Human | 2 | 2015 | 120 | 0.050 |
Why?
|
| Receptors, Opioid, mu | 1 | 2024 | 34 | 0.050 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2024 | 36 | 0.050 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2024 | 11 | 0.050 |
Why?
|
| Everolimus | 1 | 2024 | 48 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 434 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 2024 | 31 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2016 | 80 | 0.050 |
Why?
|
| Risk Factors | 4 | 2021 | 11004 | 0.050 |
Why?
|
| Pregnancy | 4 | 2019 | 7500 | 0.050 |
Why?
|
| Fibronectins | 1 | 2024 | 100 | 0.050 |
Why?
|
| Mannose | 1 | 2023 | 23 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 414 | 0.050 |
Why?
|
| Young Adult | 3 | 2025 | 10025 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2024 | 109 | 0.050 |
Why?
|
| Lipolysis | 1 | 2024 | 77 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2016 | 1012 | 0.050 |
Why?
|
| Lipase | 1 | 2024 | 88 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2023 | 17 | 0.050 |
Why?
|
| Phylogeny | 3 | 2012 | 707 | 0.050 |
Why?
|
| Urothelium | 1 | 2023 | 55 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2017 | 243 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2025 | 222 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 35 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 98 | 0.050 |
Why?
|
| Serine | 1 | 2024 | 161 | 0.050 |
Why?
|
| Cattle | 1 | 2024 | 501 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 156 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2019 | 592 | 0.050 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2025 | 152 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2023 | 47 | 0.050 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2023 | 39 | 0.050 |
Why?
|
| Auranofin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2307 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2023 | 38 | 0.050 |
Why?
|
| Agglutinins | 1 | 2022 | 7 | 0.050 |
Why?
|
| Keratin-5 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2022 | 16 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2022 | 39 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2127 | 0.050 |
Why?
|
| Ketoglutaric Acids | 1 | 2022 | 23 | 0.050 |
Why?
|
| Serotonin | 1 | 2023 | 211 | 0.050 |
Why?
|
| Fumarates | 1 | 2022 | 18 | 0.050 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 349 | 0.050 |
Why?
|
| Chemokine CXCL10 | 1 | 2022 | 52 | 0.050 |
Why?
|
| Chemokine CCL5 | 1 | 2022 | 53 | 0.050 |
Why?
|
| Cytosine | 2 | 2014 | 58 | 0.050 |
Why?
|
| Citrates | 1 | 2022 | 25 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 50 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 55 | 0.050 |
Why?
|
| Dilazep | 1 | 2021 | 2 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2022 | 149 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 137 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 342 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 69 | 0.040 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 12 | 0.040 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2022 | 205 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 38 | 0.040 |
Why?
|
| Risk | 1 | 2023 | 736 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2021 | 54 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 96 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2021 | 30 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2022 | 116 | 0.040 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2021 | 18 | 0.040 |
Why?
|
| Drosophila | 2 | 2017 | 791 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 72 | 0.040 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2022 | 76 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 697 | 0.040 |
Why?
|
| Smad3 Protein | 1 | 2021 | 54 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2023 | 304 | 0.040 |
Why?
|
| Iron-Binding Proteins | 1 | 2021 | 25 | 0.040 |
Why?
|
| Protective Factors | 1 | 2021 | 93 | 0.040 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 34 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 93 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 488 | 0.040 |
Why?
|
| Oncostatin M | 1 | 2020 | 4 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2021 | 46 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 199 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2022 | 146 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 19 | 0.040 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2020 | 18 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 70 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2021 | 173 | 0.040 |
Why?
|
| Fimbriae, Bacterial | 1 | 2020 | 40 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2021 | 110 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2020 | 19 | 0.040 |
Why?
|
| Hydrogels | 1 | 2021 | 94 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2021 | 132 | 0.040 |
Why?
|
| Microglia | 1 | 2022 | 140 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 167 | 0.040 |
Why?
|
| Adipocytes, White | 1 | 2020 | 27 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 239 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 78 | 0.040 |
Why?
|
| Desmoplakins | 1 | 2020 | 12 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2020 | 37 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2020 | 19 | 0.040 |
Why?
|
| Safety | 1 | 2021 | 214 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 367 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 121 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2022 | 203 | 0.040 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2020 | 25 | 0.040 |
Why?
|
| Dihydroergotamine | 1 | 2020 | 9 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 134 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 36 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2020 | 37 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 136 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 45 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2021 | 167 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 96 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 369 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2018 | 747 | 0.040 |
Why?
|
| Glucuronic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2019 | 16 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 36 | 0.040 |
Why?
|
| S-Adenosylmethionine | 1 | 2019 | 27 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2020 | 106 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 809 | 0.040 |
Why?
|
| Cell Shape | 1 | 2020 | 68 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2021 | 194 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2019 | 25 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2021 | 235 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 550 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 226 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 273 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2020 | 251 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2015 | 680 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 54 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 26 | 0.040 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 20 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 127 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 150 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 155 | 0.040 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2019 | 3 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2019 | 27 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 315 | 0.040 |
Why?
|
| Infant | 2 | 2025 | 13326 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 85 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 699 | 0.040 |
Why?
|
| Heterochromatin | 1 | 2019 | 54 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 617 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2020 | 180 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2021 | 240 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2018 | 12 | 0.040 |
Why?
|
| Acetanilides | 1 | 2018 | 8 | 0.040 |
Why?
|
| Internet | 2 | 2012 | 418 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 85 | 0.040 |
Why?
|
| Stomach | 1 | 2021 | 271 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 427 | 0.040 |
Why?
|
| Reproduction | 1 | 2020 | 214 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2019 | 73 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 556 | 0.040 |
Why?
|
| Allergens | 1 | 2021 | 325 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2019 | 98 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2020 | 178 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2018 | 36 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 159 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2021 | 265 | 0.040 |
Why?
|
| CELF1 Protein | 1 | 2018 | 34 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 47 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 59 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 38 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 99 | 0.030 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2018 | 3 | 0.030 |
Why?
|
| Transketolase | 1 | 2018 | 17 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2018 | 64 | 0.030 |
Why?
|
| Metribolone | 1 | 2018 | 28 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 153 | 0.030 |
Why?
|
| Liposomes | 1 | 2019 | 200 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2018 | 112 | 0.030 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 35 | 0.030 |
Why?
|
| Postmenopause | 1 | 2019 | 148 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2019 | 174 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2018 | 88 | 0.030 |
Why?
|
| Carbon Isotopes | 1 | 2018 | 230 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 332 | 0.030 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 82 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2018 | 144 | 0.030 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2017 | 20 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 828 | 0.030 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 46 | 0.030 |
Why?
|
| Host Cell Factor C1 | 1 | 2017 | 10 | 0.030 |
Why?
|
| Endocrinology | 1 | 2020 | 128 | 0.030 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2017 | 7 | 0.030 |
Why?
|
| Butanones | 1 | 2017 | 7 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 129 | 0.030 |
Why?
|
| Nitrosamines | 1 | 2017 | 15 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2017 | 25 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 38 | 0.030 |
Why?
|
| Benzo(a)pyrene | 1 | 2017 | 24 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 96 | 0.030 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2017 | 4 | 0.030 |
Why?
|
| Adenoma | 1 | 2019 | 145 | 0.030 |
Why?
|
| Peroxisomal Biogenesis Factor 2 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2017 | 11 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 115 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2017 | 32 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 181 | 0.030 |
Why?
|
| Azacitidine | 1 | 2017 | 52 | 0.030 |
Why?
|
| Nitrogenous Group Transferases | 1 | 2017 | 4 | 0.030 |
Why?
|
| Seasons | 1 | 2019 | 335 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 357 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2025 | 15013 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 22 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2017 | 2 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 67 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 53 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 130 | 0.030 |
Why?
|
| Bradycardia | 1 | 2017 | 57 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 642 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2017 | 25 | 0.030 |
Why?
|
| Diglycerides | 1 | 2017 | 16 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 289 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2017 | 31 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2017 | 96 | 0.030 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2017 | 41 | 0.030 |
Why?
|
| Calcium | 1 | 2022 | 1035 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2017 | 53 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2017 | 39 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 89 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 46 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 110 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 252 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2017 | 148 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2017 | 97 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 462 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2019 | 492 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2016 | 30 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2935 | 0.030 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2016 | 27 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 192 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 373 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 153 | 0.030 |
Why?
|
| Photoperiod | 1 | 2016 | 19 | 0.030 |
Why?
|
| Period Circadian Proteins | 1 | 2016 | 25 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 95 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3825 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2016 | 27 | 0.030 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2016 | 17 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2022 | 855 | 0.030 |
Why?
|
| Progesterone | 1 | 2018 | 441 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 304 | 0.030 |
Why?
|
| Bayes Theorem | 2 | 2009 | 309 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 214 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2016 | 189 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 542 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2022 | 1685 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 811 | 0.030 |
Why?
|
| United States | 2 | 2025 | 11839 | 0.030 |
Why?
|
| Housing, Animal | 1 | 2016 | 19 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 360 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 85 | 0.030 |
Why?
|
| Azetidines | 1 | 2016 | 63 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 120 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 80 | 0.030 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2015 | 12 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2015 | 11 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2015 | 32 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Caspases | 1 | 2016 | 157 | 0.030 |
Why?
|
| Data Mining | 1 | 2016 | 65 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2011 | 485 | 0.030 |
Why?
|
| Tenascin | 1 | 2015 | 33 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 206 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2015 | 72 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 254 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 614 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2015 | 53 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 567 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 234 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 54 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 58 | 0.030 |
Why?
|
| Vitamin D | 1 | 2017 | 196 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 170 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 139 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 235 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2015 | 65 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2015 | 226 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2017 | 361 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 4040 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 131 | 0.030 |
Why?
|
| Euchromatin | 1 | 2014 | 12 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 2014 | 14 | 0.030 |
Why?
|
| Tumor Protein p73 | 1 | 2014 | 26 | 0.030 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 775 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 271 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2014 | 55 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 44 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 544 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2014 | 35 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 198 | 0.030 |
Why?
|
| Histone Code | 1 | 2015 | 46 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 72 | 0.030 |
Why?
|
| Base Pairing | 1 | 2014 | 40 | 0.030 |
Why?
|
| Protein Kinase C beta | 1 | 2014 | 17 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 207 | 0.030 |
Why?
|
| Quinazolines | 1 | 2015 | 181 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2015 | 62 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 252 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1116 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2014 | 21 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 60 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2015 | 253 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2016 | 519 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 284 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 249 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 31 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1188 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 39 | 0.030 |
Why?
|
| Chimera | 1 | 2014 | 80 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1236 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2014 | 28 | 0.030 |
Why?
|
| CDX2 Transcription Factor | 1 | 2013 | 11 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1131 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 715 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 315 | 0.030 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2013 | 33 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 328 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 680 | 0.030 |
Why?
|
| Transgenes | 1 | 2014 | 320 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 166 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12912 | 0.020 |
Why?
|
| Side-Population Cells | 1 | 2013 | 13 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 70 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 61 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1136 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2013 | 10 | 0.020 |
Why?
|
| Depression | 1 | 2022 | 1327 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2015 | 689 | 0.020 |
Why?
|
| Skin | 1 | 2016 | 547 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 937 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 137 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 295 | 0.020 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2012 | 7 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 977 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 328 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 255 | 0.020 |
Why?
|
| Lentivirus | 1 | 2013 | 81 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2012 | 42 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 239 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 189 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 66 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 291 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1594 | 0.020 |
Why?
|
| Thiazoles | 1 | 2013 | 110 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 194 | 0.020 |
Why?
|
| Base Composition | 1 | 2012 | 71 | 0.020 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2012 | 81 | 0.020 |
Why?
|
| RNA, Plant | 1 | 2012 | 7 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2013 | 180 | 0.020 |
Why?
|
| Peptides | 1 | 2015 | 711 | 0.020 |
Why?
|
| Autopsy | 1 | 2012 | 119 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 576 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2012 | 99 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1002 | 0.020 |
Why?
|
| Echocardiography | 1 | 2017 | 1139 | 0.020 |
Why?
|
| Ruminococcus | 1 | 2011 | 11 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2012 | 280 | 0.020 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2011 | 11 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 72 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 158 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2012 | 93 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2012 | 199 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 118 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 946 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 92 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2398 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2611 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 152 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3636 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 284 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 492 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 258 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 569 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 900 | 0.020 |
Why?
|
| Locus Control Region | 1 | 2008 | 7 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2008 | 15 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2011 | 316 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 89 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2009 | 208 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 538 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1457 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1503 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3717 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 481 | 0.010 |
Why?
|
| Computers | 1 | 2006 | 68 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2006 | 117 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 1825 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17681 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 3350 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 599 | 0.010 |
Why?
|